Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus

被引：1
|
作者：
Kaplan, Alyson [1 ]
DeHaan, Elliott [2 ]
Maltz, Charles [1 ]
机构：
[1] New York Presbyterian, Dept Med, Div Gastroenterol & Hepatol, Weill Cornell Sch Med, New York, NY 10065 USA
[2] New York Presbyterian, Dept Med, Div Infect Dis, Weill Cornell Sch Med, New York, NY USA
来源：
ACG CASE REPORTS JOURNAL | 2021年 / 8卷 / 05期
关键词：
MONOCLONAL-ANTIBODY; HIV-1;
D O I：
10.14309/crj.0000000000000594
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Despite the decreasing morbidity associated with the human immunodeficiency virus (HIV), a large percentage of persons with HIV have at least 1 drug resistance mutation. Ibalizumab, a recently approved drug, targets multidrug-resistant HIV. We present a case of reactivation of hepatitis B after initiation of ibalizumab therapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires
    Ritacco, V
    DiLonardo, M
    Reniero, A
    Ambroggi, M
    Barrera, L
    Dambrosi, A
    Lopez, B
    Isola, N
    deKantor, IN
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03): : 637 - 642
  • [22] Nosocomial transmission of human immunodeficiency virus and subsequent transmission of multidrug-resistant tuberculosis in a healthcare worker
    Ridzon, R
    Kenyon, T
    LuskinHawk, R
    Schultz, C
    Valway, S
    Onorato, IM
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1997, 18 (06): : 422 - 423
  • [23] Papulonecrotic tuberculid in a human immunodeficiency virus type-1 patient with multidrug-resistant tuberculosis
    Fernandes, C
    Maltez, F
    Lourenço, S
    Morgado, A
    Proença, R
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (03) : 369 - 370
  • [24] BRONCHOESOPHAGEAL FISTULA DUE TO MULTIDRUG-RESISTANT TUBERCULOSIS IN A PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    ASNIS, DS
    SALTZMAN, HP
    GIRON, JA
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) : 1061 - 1062
  • [25] Multidrug resistant tuberculosis associated with human immunodeficiency virus
    Muntean, Petru Emil
    PNEUMON, 2019, 32 (04)
  • [26] Immunosuppressive Therapy and Hepatitis B Virus Reactivation
    Koksal, Iftihar
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2016, 22 (03): : 69 - 73
  • [27] Hepatitis B virus reactivation and alemtuzumab therapy
    Iannitto, E
    Minardi, V
    Calvaruso, G
    Mulè, A
    Ammatuna, E
    Trapani, RD
    Ferraro, D
    Abbadessa, V
    Craxí, A
    Stefano, RD
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (03) : 254 - 258
  • [28] Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?
    Chung, Sung Won
    Chang, Young
    Lee, Hyo Young
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [29] Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States
    Millham, Lucia R. I.
    Scott, Justine A.
    Sax, Paul E.
    Shebl, Fatma M.
    Reddy, Krishna P.
    Losina, Elena
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 83 (02) : 148 - 156
  • [30] Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
    Kanada, Aimi
    Takehara, Tetsuo
    Ohkawa, Kazuyoshi
    Kato, Michio
    Tatsumi, Tomohide
    Miyagi, Takuya
    Sakamori, Ryotaro
    Yamaguchi, Shinjiro
    Uemura, Akio
    Kohga, Keisuke
    Sasakawa, Akira
    Hikita, Hayato
    Kawamura, Kiyomi
    Kanto, Tatsuya
    Hiramatsu, Naoki
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2008, 38 (06) : 622 - 628
12345